Royal College of Surgeons in Ireland
Browse
bmjebm-2021-111905.full (1).pdf (752.04 kB)

Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study

Download (752.04 kB)
journal contribution
posted on 2022-07-28, 08:29 authored by Barbara ClyneBarbara Clyne, Lisa Hynes, Colette Kirwan, Máire McGeehan, Paula Byrne, Martha Killilea, Susan SmithSusan Smith, Máirín Ryan, Claire Collins, Michelle O’Neill, Emma WallaceEmma Wallace, Andrew W Murphy, Maureen E Kelly

Objectives: To describe perceptions of providing, and using rapid evidence, to support decision making by two national bodies (one public health policy and one front-line clinical practice) during the COVID-19 pandemic.

Design: Descriptive qualitative study (March-August 2020): 25 semistructured interviews were conducted, transcribed verbatim and thematically analysed.

Setting: Data were obtained as part of an evaluation of two Irish national projects; the Irish COVID-19 Evidence for General Practitioners project (General Practice (GP) project) which provided relevant evidence to address clinical questions posed by GPs; and the COVID-19 Evidence Synthesis Team (Health Policy project) which produced rapid evidence products at the request of the National Public Health Emergency Team.

Participants: Purposive sample of 14 evidence providers (EPs: generated and disseminated rapid evidence) and 11 service ssers (SUs: GPs and policy-makers, who used the evidence).

Main outcome measures: Participant perceptions.

Results: The Policy Project comprised 27 EPs, producing 30 reports across 1432 person-work-days. The GP project comprised 10 members from 3 organisations, meeting 49 times and posting evidence-based answers to 126 questions. Four unique themes were generated. 'The Work' highlighted that a structured but flexible organisational approach to producing evidence was essential. Ensuring quality of evidence products was challenging, particularly in the context of absent or poor-quality evidence. 'The Use' highlighted that rapid evidence products were considered invaluable to decision making. Trust and credibility of EPs were key, however, communication difficulties were highlighted by SUs (eg, website functionality). 'The Team' emphasised that a highly skilled team, working collaboratively, is essential to meeting the substantial workload demands and tight turnaround time. 'The Future' highlighted that investing in resources, planning and embedding evidence synthesis support, is crucial to national emergency preparedness.

Conclusions: Rapid evidence products were considered invaluable to decision making. The credibility of EPs, a close relationship with SUs and having a highly skilled and adaptable team to meet the workload demands were identified as key strengths that optimised the utilisation of rapid evidence.

Ethics approval: Ethical approval was obtained from the National Research Ethics Committee for COVID-19-related Research, Ireland.

Funding

Health Research Board (HRB) Emerging Investigator Award (EIA-2019-09)

Irish College of General Practitioners (ICGP)

Academic Departments of General Practice in Ireland (AUDGPI)

HRB Primary Care Clinical Trials Network in Ireland (PCCTNI)

History

Comments

The original article is available at https://ebm.bmj.com/

Published Citation

Clyne B, et al. Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study. BMJ Evid Based Med. 2022:bmjebm-2021-111905.

Publication Date

30 June 2022

PubMed ID

35772940

Department/Unit

  • General Practice

Publisher

BMJ Publishing Group Ltd

Version

  • Published Version (Version of Record)

Usage metrics

    Royal College of Surgeons in Ireland

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC